DrugPatentWatch Database Preview
LEVO-T Drug Profile
» See Plans and Pricing
When do Levo-t patents expire, and what generic alternatives are available?
Levo-t is a drug marketed by Cediprof Inc and is included in one NDA. There is one patent protecting this drug.
This drug has eight patent family members in seven countries.
The generic ingredient in LEVO-T is levothyroxine sodium. There are ten drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
US ANDA Litigation and Generic Entry Outlook for Levo-t
A generic version of LEVO-T was approved as levothyroxine sodium by MYLAN on June 5th, 2002.
Summary for LEVO-T
| International Patents: | 8 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 15 |
| Bulk Api Vendors: | 64 |
| Patent Applications: | 1,636 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for LEVO-T |
| DailyMed Link: | LEVO-T at DailyMed |
Pharmacology for LEVO-T
| Drug Class | l-Thyroxine |
US Patents and Regulatory Information for LEVO-T
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-001 | Mar 1, 2002 | AB1,AB2,AB3 | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-007 | Mar 1, 2002 | AB1,AB2,AB3 | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-004 | Mar 1, 2002 | AB1,AB2,AB3 | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LEVO-T
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-001 | Mar 1, 2002 | Start Trial | Start Trial |
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-004 | Mar 1, 2002 | Start Trial | Start Trial |
| Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-009 | Mar 1, 2002 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LEVO-T
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 5295301 | Start Trial |
| World Intellectual Property Organization (WIPO) | 0174448 | Start Trial |
| Israel | 152024 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
